Regeneron has bought Oxular, a UK-based specialist in retinal diseases, in a move that bolsters its already strong position ...

Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular edema ...

Macular degeneration is an eye disease, usually age-related, that damages one's macula and affects central vision. Almost 20 million Americans suffer from macular degeneration, according to ...

Regeneron has scooped up Oxular, a retinal-disease-focused company based in the U.K., closing the deal at the very end of ...

Over the past two decades, the role of vitreomacular adhesion in vitreomacular interface pathologies, such as vitreomacular traction syndrome, epiretinal membrane and macular hole, has been ...

Even people who do reach late-stage AMD are often able to keep their normal vision for most of their life. AMD is a group of long-term (chronic) degenerative eye diseases. It's sometimes just called ...

Two common forms of retinal degeneration are retinitis pigmentosa and macular degeneration. Retinitis pigmentosa (RP) affects approximately 1.5 million people worldwide. Over 3,000 mutations in at ...

Macular telangiectasia, sometimes referred to as idiopathic juxtafoveal macular telangiectasia, is a disease that affects the part of the eye called the macula, causing degradation or loss of central ...

Discover how a new eye drop treatment may prevent the loss of vision associated with dry age-related macular degeneration, ...

A wide range of diseases and health factors can raise your risk of developing macular degeneration and increase your chances that it progresses to an advanced form. Smoking tobacco and/or regular ...